BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 5730198)

  • 1. [On the therapy of diabetes mellitus with biguanides].
    Riess PJ; Saum R
    Med Klin; 1968 May; 63(19):764-7. PubMed ID: 5730198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Guanidine derivatives in the treatment of patients with diabetes mellitus].
    Liashko KIa; Severova TM
    Sov Med; 1974 Jun; 37(6):70-5. PubMed ID: 4211010
    [No Abstract]   [Full Text] [Related]  

  • 3. [Oral treatment of diabetes mellitus with the new sulfonylurea tolazamide].
    Vogel G; Krummel E
    Arzneimittelforschung; 1969 Jul; 19(7):1128-30. PubMed ID: 5394514
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of diabetes mellitus with Silubin-retard].
    Huczek-Glebocki J; Piotrowska R; Ruciński M
    Pol Tyg Lek; 1970 Jan; 25(1):26-7. PubMed ID: 5414476
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modern aspects of pathogenesis in diabetes mellitus].
    Spanár E; Zahradny V; Uhrín P; Levcik A
    Z Gesamte Inn Med; 1974 Jun; 29(11):433-8. PubMed ID: 4849195
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of biguanides on insulin sensitivity of maturity onset diabetics (author's transl)].
    Lisch HJ; Sailer S; Braunsteiner H
    Wien Klin Wochenschr; 1980 Apr; 92(8):266-9. PubMed ID: 6996339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P; Mughini L
    Minerva Med; 1974 Aug; 65(59):383-9. PubMed ID: 4213556
    [No Abstract]   [Full Text] [Related]  

  • 8. [The biguanides-insulin combination in the treatment of certain types of diabetes].
    Leng-Lévy J; Leng B; Aubertin J; Lacut JY; Le Gall F; Boget JC; Lenoir MP
    Bord Med; 1972 Dec; 5(19):2659-64. PubMed ID: 4659799
    [No Abstract]   [Full Text] [Related]  

  • 9. [On the clinical use of biguanides].
    Haese E
    Arzneimittelforschung; 1969 Apr; 19(4):633-8. PubMed ID: 5819164
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of the pancreas glycogenase under oral biguanide and tolbutamide loading in diabetes].
    Schilling I; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):180-5. PubMed ID: 5595284
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucose-lactic acid metabolism during clinical use of biguanides].
    Pedersen J
    Ugeskr Laeger; 1973 Jul; 135(31):1632-5. PubMed ID: 4585752
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress in the therapy of diabetes].
    Raptis S; Rothenbuchner G; Pfeiffer EF
    Wien Med Wochenschr; 1971 Apr; 121(14):261-9. PubMed ID: 5559791
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of diabetes therapy with Silubin retard].
    Kopp H
    Med Klin; 1966 Apr; 61(15):592-6. PubMed ID: 4869026
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma insulin studies in two hundred patients with diabetes mellitus.
    McKiddie MT; Buchanan KD; Hunter IA
    Q J Med; 1969 Oct; 38(152):445-65. PubMed ID: 5355537
    [No Abstract]   [Full Text] [Related]  

  • 15. [Biguanides, glycemia and insulinemia (author's transl)].
    Kulenda Z; Dub O
    Cas Lek Cesk; 1974 Sep; 113(39):1201-3. PubMed ID: 4424987
    [No Abstract]   [Full Text] [Related]  

  • 16. [Resistance to insulin, brittle abetes and reaction of the fasininsulin activity during the administration of biguanides].
    Klein W; Hole P; Dietzmann HB; Buding A
    Munch Med Wochenschr; 1969 Sep; 111(38):1908-12. PubMed ID: 5394856
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of diabetes mellitus with biguanides].
    Tikhonova EP; Kopelovich MA; Grinchenko TS; Beliaeva GA; Chetvertakova ZhT
    Vrach Delo; 1975 Sep; (9):73-6. PubMed ID: 1210305
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mechanism of action of biguanides and their place in the modern therapy of diabetes mellitus].
    Fövényi J
    Orv Hetil; 1970 Jun; 111(26):1503-7. PubMed ID: 4916664
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I; Zilker T; Schweigart U; Ermler R; Paterek K; Bottermann P
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1388-91. PubMed ID: 417495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Application of the method of continuois recording of glycemia to the study of the action of hypoglycemic agents in the diabetic].
    Drouin P; Mejean L; Guisard D; Debry G
    Nutr Metab; 1974; 16(5):261-7. PubMed ID: 4836869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.